Dongwha Pharm.Co.,Ltd (KOSE:A000020) agreed to acquire additional 11.18% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Technology Guarantee Fund Venture Investment Center for KRW 4 billion on September 24, 2020. As per transaction, Dongwha Pharm.Co.,Ltd will acquire 0.42 million share of MEDYSSEY Co.,Ltd at an offer price of KRW 9700 per share. Technology Guarantee Fund Venture Investment Center will dispose 0.24 million shares representing 6.55% stake of MEDYSSEY Co.,Ltd to Dongwha Pharm.Co.,Ltd. Upon completion, Dongwha Pharm.Co.,Ltd will hold 64.5% stake in MEDYSSEY Co.,Ltd.